Trauma patients rushed to A&E with serious eye injuries can now benefit from a ground-breaking sight-saving wound dressing made from amniotic membrane.
The unique biological dressing ‘Omnigen’ was originally developed by researchers in The University of Nottingham’s School of Medicine, work which led to the formation of a University spin-out company NuVision Biotherapies. Omnigen has the potential to revolutionise the treatment for emergency cases of ophthalmic wounds including abrasions, burns and more serious perforations, as well as planned operations on the eye.
NuVision has now been granted a full licence by the Human Tissue Authorityto distribute Omnigen, and patients coming for treatment at Nottingham University NHS Trust’s Queen’s Medical Centre are among the first to try this innovative new treatment.
Posted on Wednesday 29th June 2016